Connect with us

Technology

Light AI Announces Expansion of its Wellness Platform

Published

on

Revolutionizing Family Healthcare with Advanced AI Solutions for
Group A Strep, COVID-19, and Conjunctivitis

VANCOUVER, BC, April 16, 2025 /CNW/ – Light AI Inc. (“Light AI” or the “Company”) (CBOE CA: ALGO) (FSE: 0HC) (OTCQB: OHCFF), a healthcare technology company focused on developing artificial intelligence health diagnostic and wellness solutions, is excited to announce that its innovative wellness platform, anticipated to launch in Q3 of 2025, is expanding its capabilities to help users rule out COVID-19 and conjunctivitis (pink eye) in addition to Strep A.

The wellness platform is a direct-to-consumer product designed to support the quick detection and management of these conditions and will serve as a cornerstone in Light AI’s expanding suite of healthcare tools aimed at supporting millions of families and individuals worldwide.

These additional medical conditions expand Light AI’s addressable market and are anticipated to enhance revenue and opportunities for licensing and partnership.  This illustrates the Company’s progress toward its ultimate goal of being a one-stop application to enhance health and wellness.

“Timely diagnosis is known to drive better health outcomes, yet nearly 50% of the global population lacks access to basic diagnostics, exposing a massive gap in care and a high-growth market ripe for innovation,” says Peter Whitehead CEO of Light AI. “For these reasons, we are thrilled to introduce our comprehensive wellness platform, which will empower families and individuals to manage common yet impactful health issues more effectively.”

Strep A

Group A Strep, a common yet potentially serious infection, can cause significant health complications if not managed properly.1 Light AI’s app will leverage advanced machine learning (ML) algorithms to provide accurate and timely diagnosis, empowering families to manage this condition more effectively. Light AI’s management team is confident that this application will be a powerful attractor, encouraging the adoption of other critical healthcare solutions.

____________________________________

1 Centers for Disease Control and Prevention (CDC) (2021). Group A Streptococcal (GAS) Disease. Retrieved from CDC Website.

COVID-19

The persistent presence of COVID-19 continues to strain healthcare resources, particularly in settings housing high-risk individuals such as long-term care facilities. These establishments face ongoing challenges related to infection control, staffing, and adequate vaccination coverage among residents and staff.2

__________________________________

2 World Health Organization (WHO) (2021). COVID-19: Operational guidance for maintaining essential health services during an outbreak. Retrieved from WHO Website.

Conjunctivitis

Light AI’s machine learning team has successfully developed an algorithm that can rapidly advise if affected individuals can rule out conjunctivitis with an impressive 99% accuracy rate. Conjunctivitis is a highly infectious condition affecting approximately 6 million people annually in the USA alone, and can lead to severe complications such as cellulitis, orbital cellulitis, keratitis, corneal ulcers, and scarring, potentially increasing the risk of permanent vision impairment if left untreated.3

Light AI’s dedicated team is currently working to advance diagnostics on healthcare issues and will provide updates as new algorithms are refined. This expanded ecosystem will not only provide economies of scale to support market demand but will also generate valuable data to enhance predictive algorithms for future healthcare solutions. 

_____________________________________

3 National Eye Institute (NEI) (2021). Facts About Conjunctivitis (pink eye). Retrieved from NEI Website.

About Light AI Inc. (CBOE CA: ALGO / FSE: 0HC / OTCQB: OHCFF)

Light AI Inc. is a technology company focused on developing artificial intelligence health diagnostic solutions. Light AI is developing a technology platform which represents the next generation of patient management: it applies AI algorithms to smartphone images—starting with images of Strep A—to identify the disease in seconds. Its patented, app-based solution requires no swabs, lab tests or proprietary hardware of any kind—its hardware platform is the 4.5 billion smartphones that exist in the world today. Light AI is at the forefront of developing innovative diagnostic solutions aimed at improving healthcare delivery worldwide. Their cutting-edge AI powered technology offers rapid, accurate, and cost-effective diagnostic tools designed to address critical healthcare challenges.

In pre-FDA validation studies, Light AI’s algorithm demonstrated remarkable accuracy in differentiating between viral and bacterial pharyngitis, specifically targeting Group A Streptococcus (GAS). The algorithm achieved a 96.57% accuracy rate and attained a Negative Predictive Value of 100%, indicating its high reliability in confirming the absence of Streptococcus A infection. Viral and GAS pharyngitis affects over 600 million people annually worldwide. If left untreated, GAS pharyngitis can lead to serious complications such as Rheumatic Heart Disease (RHD), which imposes a global economic burden exceeding $1 trillion annually. Light AI’s technology offers a significant advancement in the accurate and timely diagnosis of GAS pharyngitis, potentially reducing the incidence of RHD and its associated costs. Light AI’s approach to applying AI to smartphone images can be expanded to other throat conditions, as well as other areas of analysis, such as the human eye and skin. Light AI’s vision is to combine the smartphone with AI in-the-Cloud to create a Digital Clinical Lab that provides quick and accessible diagnosis for countless conditions that today require expensive and time-consuming imaging or lab processes.

ON BEHALF OF THE COMPANY

“George Reznik”
George Reznik
Chief Financial Officer
greznik@light.ai

For more information, please contact the Company at investors@light.ai or visit https://light.ai/.

Website: https://light.ai/
LinkedIn: LinkedIn/company/Light AI
X (Formerly Twitter): @lightaihealth

Forward-Looking Information:

This news release includes information, statements, beliefs and opinions which are forward-looking, and which reflect current estimates, expectations and projections about future events, including, but not limited to, the Company’s research and development and commercialization initiatives, the anticipated inflection of the business, the opportunity related to the commercialization of the Company’s software, and other statements that contain words such as “believe,” “expect,” “project,” “should,” “seek,” “anticipate,” “will,” “intend,” “positioned,” “risk,” “plan,” “may,” “estimate” or, in each case, their negative and words of similar meaning. By its nature, forward-looking information involves a number of risks, uncertainties and assumptions that could cause actual results or events to differ materially from those expressed or implied by the forward-looking information. These risks, uncertainties and assumptions could adversely affect the outcome of the plans and events described herein. Readers should not place undue reliance on forward-looking information, which is based on the information available as of the date of this news release. For a list of the factors that may affect any of the Company’s forward-looking statements, please refer to the Company’s annual information form dated April 14, 2025 and other filings made by the Company with the Canadian securities regulatory authorities (which may be viewed under its SEDAR+ profile at www.sedarplus.ca). Light AI disclaims any intention or obligation to update or revise any forward-looking information contained in this new release, whether as a result of new information, future events or otherwise, unless required by applicable law. The forward-looking information included in this news release is expressly qualified in its entirety by this cautionary statement.

SOURCE Light AI Inc.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Technology

/C O R R E C T I O N — Applied Intuition, Inc./

Published

on

By

In the news release, Applied Intuition Collaborates with Heidelberg Materials to Advance Innovation in Quarry Operations with Autonomous Haulage Fleets, issued 30-Apr-2026 by Applied Intuition, Inc. over PR Newswire, we are advised by the company that changes have been made. The complete, corrected release follows, with additional details at the end:

Applied Intuition Collaborates with Heidelberg Materials to Advance Innovation in Quarry Operations with Autonomous Haulage Fleets

Deployment brings intelligent, vehicle-based autonomy to Australia, establishing a new operating model for construction and mining environments.

SUNNYVALE, Calif., April 30, 2026 /CNW/ — Applied Intuition, Inc., a leader in physical AI, today announced its collaboration with Heidelberg Materials, one of the world’s largest integrated manufacturers of building materials and solutions, to deploy autonomous haulage systems for Heidelberg Materials’ quarry operations, starting at a site in Australia.

Applied Intuition will provide its Self-Driving System (SDS) for Construction to support autonomous haulage operations within Heidelberg Materials’ fleet of construction and mining vehicles in Australia. The deployment marks the next real-world application of Applied Intuition’s autonomy platform in industrial environments. Upon successful completion, it will support the expansion of autonomous operations within Heidelberg Materials’ broader Australian network.

The collaboration also challenges the standard industry model. While autonomy solutions traditionally target the largest quarry sites, this system is designed for smaller operations, including those running just two 40-ton trucks, making it deployable across quarry sites of varying size worldwide.

“No two quarry or construction sites operate the same way, with different layouts, constraints and economics,” said Qasar Younis, co-founder and CEO of Applied Intuition. “We’ve built our platform to adapt to that reality. This partnership shows we can take the same core system used in large mining operations and apply it to smaller, infrastructure-constrained quarry sites, scaling it across hundreds of unique locations.”

For Heidelberg Materials, the partnership is aimed at enhancing safety and operational performance. It also reflects the need for an autonomy solution that can operate at large sites and smaller ones too, whereas traditional autonomous haulage systems are often too infrastructure-heavy or costly to scale. For Applied Intuition, it serves as a proof point that its autonomy platform is designed not just for one-off deployments, but for global scale across construction, quarry and mining environments of any size.

Applied Intuition’s system runs directly on the vehicle, with integrated perception, decision-making and safety systems onboard, enabling reliable operation without constant connectivity or heavy site infrastructure.

The collaboration builds on Applied Intuition’s growing presence in construction and mining autonomy and reinforces its broader physical AI strategy. The same core platform has already been deployed in other industries, including trucking and defense, with learnings from each domain contributing to continuous system improvements. Applied Intuition’s SDS platform strategy also enables the company to bring technologies proven in other domains into construction and mining, helping accelerate development and deployment.

Through this project, Applied Intuition demonstrates the range of its autonomy platform, from some of the largest mining trucks in the world to smaller quarry vehicles operating in constrained, lower-infrastructure environments. Together, these deployments highlight the company’s approach to building scalable autonomy for construction and mining from the ground up.

To learn more about how Applied Intuition is building the future of construction autonomy, visit applied.co.

About Applied Intuition
Applied Intuition, Inc. is powering the future of physical AI. Founded in 2017 and now valued at $15 billion, the Silicon Valley company is creating the digital infrastructure needed to bring intelligence to every moving machine on the planet. Applied Intuition services the automotive, defense, trucking, construction, mining and agriculture industries in three core areas: tools and infrastructure, operating systems and autonomy. Eighteen of the top 20 global automakers, as well as the United States military and its allies, trust the company’s solutions to deliver physical intelligence. Applied Intuition is headquartered in Sunnyvale, California, with offices in Washington, D.C.; San Diego; Ft. Walton Beach, Florida; Ann Arbor, Michigan; London; Stuttgart; Munich; Stockholm; Gothenburg, Sweden; Bangalore; Seoul; and Tokyo. Learn more at applied.co.

Correction: An earlier version of this release incorrectly stated the location of the site noted in the first paragraph.

View original content:https://www.prnewswire.com/news-releases/applied-intuition-collaborates-with-heidelberg-materials-to-advance-innovation-in-quarry-operations-with-autonomous-haulage-fleets-302758224.html

SOURCE Applied Intuition, Inc.

Continue Reading

Technology

MOREH Demonstrates Production-Ready LLM Inference on Tenstorrent Galaxy, Achieving DGX A100-Class Performance with Improved Cost Efficiency

Published

on

By

Reduces HBM Costs with GPU–Tenstorrent Heterogeneous Distributed Serving
First unveiled at Tenstorrent’s launch event, TT-Deploy, in San Francisco on May 1

SANTA CLARA, Calif., May 1, 2026 /PRNewswire/ — Moreh, an AI infrastructure software company, led by CEO Gangwon Jo, announced that it has successfully validated LLM inference performance on the Tenstorrent Galaxy Wormhole system using its proprietary ‘MoAI Inference Framework.’

Based on tests across leading Mixture-of-Experts (MoE) models—including GPT-OSS, Qwen, GLM, and DeepSeek—Moreh achieved LLM inference performance on Tenstorrent Galaxy Wormhole matching or surpassing NVIDIA DGX A100-class systems, demonstrating a compelling alternative to conventional GPU-centric AI infrastructure.

Moreh also improved cost efficiency by implementing a disaggregated serving architecture that combines GPUs with Tenstorrent Wormhole chips. By utilizing Tenstorrent processors as dedicated prefill accelerators, the company reduced reliance on high-cost HBM and lowered overall infrastructure costs.

The results were first unveiled at Tenstorrent’s launch event, TT-Deploy, held on May 1 in San Francisco.

As a strategic partner of Tenstorrent and a major external contributor to Metalium, Moreh showcased a live LLM inference demo at the event. Building on its experience operating AMD GPU-based production environments in real-world data centers, the company presented its latest technical achievements in ‘Production-Ready LLM Inference on Tenstorrent Galaxy.’

MoAI Inference Framework is a disaggregated inference solution that enables unified operation of heterogeneous GPUs and NPUs—including NVIDIA, AMD, and Tenstorrent—within a single cluster. This allows enterprises to build flexible AI infrastructure strategies without vendor lock-in.

Moreh CEO Gangwon Jo stated, “Achieving production-grade LLM inference performance and stability on Tenstorrent-based systems marks a significant milestone,” and added, “We will continue to enhance performance through deeper optimization across heterogeneous architectures and closer integration with Tenstorrent NPUs.”

Moreh is developing its own core AI infrastructure engine and, through its foundation LLM subsidiary Motif Technologies, is building end-to-end capabilities spanning both infrastructure and model domains. Simultaneously, the company is making its mark in the global market through collaborations with key partners such as AMD, Tenstorrent, and SGLang.

View original content to download multimedia:https://www.prnewswire.com/news-releases/moreh-demonstrates-production-ready-llm-inference-on-tenstorrent-galaxy-achieving-dgx-a100-class-performance-with-improved-cost-efficiency-302760562.html

SOURCE Moreh

Continue Reading

Technology

US Startup PerZeption Inc. Announces Collaboration with Alcon Research

Published

on

By

BOSTON, MA, May. 1, 2026 /PRNewswire/ — Advancements in vision correction evaluation require methods that offer both precision and efficiency in detecting clinically meaningful visual differences. Addressing this need, PerZeption is set to present new data validating its AIM+ CSF modeling technology at the Association of Research in Vision and Ophthalmology (ARVO) annual meeting.

Attendees are invited to learn more about this innovative approach during the poster session on May 4, 2026, from 11:15 AM to 1:00 PM, at posterboard #0941.

“We are very excited to collaborate with Alcon, one of the largest companies within the Ophthalmology sector worldwide. “, Dr. Jan Skerswetat said. “The results, presented by Dr Derek Nankivil, indicate that our technology enables rapid, repeatable, and highly sensitive assessment of contrast vision.”

The abstract, titled ‘AIM+ CSF modeling enables efficient detection of clinically meaningful visual differences,’ outlines how PerZeption’s technology supports sensitive, low-burden visual assessment for vision correction evaluation. Data indicates that with approximately six adaptive displays of stimuli and two repeats, studies show around 20 subjects can achieve 90% power to detect a 1 JND (Just Noticeable Difference) change in AULCSF (Area Under the Log Contrast Sensitivity Function). This research also demonstrates AIM+ CSF’s stable repeatability in less than 3 minutes, absence of bias, and robust performance, validating its role as an effective tool for objective visual performance evaluation.

This joint effort highlights a shared dedication to advancing ophthalmology research and developing precise tools for visual assessment. The ARVO annual meeting serves as the world’s foremost event for ophthalmology research, offering a vital platform for sharing scientific breakthroughs and fostering dialogue within the global vision science community.

“In addition to all the exciting research presentations that leverage PerZeption technology at this years’ ARVO meeting, we are also proud to be showcasing PerZeption’s battery of functional tests at our booth, #4027.” Dr. Skerswetat added and noted that there will be opportunities to try out our technology.

This presentation at ARVO represents a significant step in the validation and recognition of PerZeption’s contributions to advanced visual assessment technologies.

About PerZeption Inc
PerZeption delivers vision testing with a rapid, self-administered, and adaptive psychophysical platform delivered via cloud-based software on standard tablets or all-in-one computers. Our flagship platform, Angular Indication Measurement (AIM), enables testing of over 20 visual functions. Our novel approach equips researchers and clinicians with a comprehensive range of visual functions and introduces new tests for which there are no currently available devices. We reduce chairtime. Self-administered tests on a single device in combination with proprietary methods that rapidly assess vision, reduce user’s burden and require minimal training or space, unlike bulky, specialized single-use devices. Finally, cloud-based delivery supports secure in-clinic and remote testing, ensuring consistent, trackable results for clinicians and pharmaceutical companies. 

View original content:https://www.prnewswire.com/news-releases/us-startup-perzeption-inc-announces-collaboration-with-alcon-research-302760563.html

SOURCE PerZeption

Continue Reading

Trending